^
No biomarker
Nasopharyngeal Carcinoma
toripalimab
Sensitive
:
A1
No biomarker
Nasopharyngeal Carcinoma
GC
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
DP
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
TPF
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
oxaliplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
doxorubicin hydrochloride
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
ifosfamide
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
vinorelbine tartrate
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
irinotecan
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
capecitabine
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
5-fluorouracil
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
docetaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
paclitaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
nedaplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + paclitaxel + epirubicin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + docetaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + paclitaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cetuximab
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
carboplatin + gemcitabine
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
carboplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
ADX-2191
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
gemcitabine
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
nivolumab
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
pembrolizumab
Sensitive
:
A2
TMB-H
Nasopharyngeal Carcinoma
pembrolizumab
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
cisplatin + gemcitabine
Sensitive
:
A2
PD-L1 expression
Nasopharyngeal Carcinoma
pembrolizumab
Sensitive
:
C1
PD-L1 expression
Nasopharyngeal Carcinoma
penpulimab
Sensitive
:
C2
CCR4 overexpression
Nasopharyngeal Carcinoma
FLX475
Sensitive
:
C3